Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intramuscular ketamine for pediatric procedural sedation
IRCT20260710070117N1Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ketamine in procedural pain and anxiety disorder (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Sedation success rate. Started Oct 2026; status: recruiting.
02
Drugs
ketamine
03
Conditions
procedural painanxiety disorder
Beyond the preview
Go deeper on IRCT20260710070117N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260710070117N1.